多囊卵巢综合征女性呼吸功能受损:基于人群匹配对照研究
该研究对145名多囊卵巢综合征(PCOS)女性(原队列54%)进行8年临床随访,并按1:3匹配年龄、性别和吸烟状态的对照。PCOS组医生诊断哮喘(DDA)比例高于对照(19% vs 9%;P < 0.01),FEV1%预计值和FVC%预计值均低于对照(93.7 vs 102.0;94.5 vs 103.7;均P < 0.01),提示阻塞性与限制性通气障碍并存。孕期二甲双胍暴露未影响随访时呼吸功能。
要点
- PCOS女性医生诊断哮喘比例显著高于匹配对照(19% vs 9%)。
- PCOS女性存在阻塞性及限制性通气功能下降。
- 孕期二甲双胍暴露未影响随访时呼吸功能。
核心结论
- PCOS女性较年龄和吸烟状态匹配的对照报告更多医生诊断哮喘,且肺功能显示阻塞性与限制性成分均下降。
研究设计与样本
- 8年临床随访研究,纳入145名PCOS女性(原队列54%),按1:3匹配性别、年龄和吸烟状态的对照。
- PCOS组来自原始孕期随机接受二甲双胍或安慰剂的Pilot和PregMet研究。
- 对照来自基于人群的HUNT研究队列。
主要发现
- PCOS组医生诊断哮喘比例为19%,对照组为9%(P < 0.01)。
- PCOS组FEV1%预计值为93.7,对照组为102.0(P < 0.01)。
- PCOS组FVC%预计值为94.5,对照组为103.7(P < 0.01)。
- 孕期二甲双胍暴露未影响随访时呼吸功能。
临床怎么用
- 对PCOS女性应关注哮喘病史及呼吸症状,必要时进行肺功能评估。
局限性
- 需要进一步研究以阐明这些观察结果的潜在发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Increased prevalence of asthma has been reported from epidemiological studies in women with polycystic ovary syndrome (PCOS). OBJECTIVE: To investigate respiratory function in women with PCOS compared with controls in a clinical setting. DESIGN: An 8-year clinical follow-up study including self-reported asthma diagnoses and spirometry of women with PCOS randomized to metformin or placebo during pregnancy in the original studies (the Pilot and the PregMet-study), compared with matched controls from a population-based cohort study (The HUNT Study). SETTING: Secondary and tertiary care centers. PARTICIPANTS: A total of 145 women with PCOS (54% of original cohort) were matched 1:3 to controls, on gender, age, and smoking-status. MAIN OUTCOMES AND MEASURES: Self-reported doctor-diagnosed asthma (DDA), percentage of predicted forced expiratory volume in the first second of expiration (FEV1 % predicted), percentage of predicted forced vital capacity (FVC % predicted). RESULTS: Women with PCOS reported more DDA compared with controls (19% vs 9%; P < 0.01). Spirometry indicated a combined obstructive (FEV1 % predicted, 93.7 vs 102.0; P < 0.01) and restrictive (FVC % predicted, 94.5 vs 103.7; P < 0.01) respiratory impairment in PCOS compared with controls. Metformin in pregnancy did not affect respiratory function at follow-up. CONCLUSION: Women with PCOS reported higher prevalence of DDA compared with controls matched for age and smoking status. In addition, respiratory function was decreased, with both obstructive and restrictive components. Further insight to the underlying pathogenesis of these observations is needed. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: The PregMet study: NCT00159536. The Pilot study: NCT03259919.
引用
- Underdal MO, Salvesen Ø, Henriksen AH, et al. Impaired Respiratory Function in Women With PCOS Compared With Matched Controls From a Population-Based Study. J Clin Endocrinol Metab. 2020. PMID: 31613965. doi:10.1210/clinem/dgz053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。